Protein S GLA-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency

Blood

Volumn 100, Issue 8, 2002, Pages 2812-2819

  Rezende, Suely M ^a,b   Lane, David A ^a,b   Mille Baker, Blandine ^a,b   Samama, Michel M ^a,b   Conard, Jacqueline ^a,b   Simmonds, Rachel E ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HÔTEL DIEU   (France)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHOLIPID; PROTEIN S; VITAMIN K GROUP;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CASE REPORT; EXON; FEMALE; HETEROZYGOTE; HUMAN; MISSENSE MUTATION; PEDIGREE; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; SITE DIRECTED MUTAGENESIS; THROMBOSIS; WESTERN BLOTTING;

EID: 0037108445     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0909     Document Type: Article

References (44)

1. Simmonds RE, Lane DA. Regulation of coagulation. In: Loscalzo J, Schafer Al, eds. Thrombosis and Hemorrhage. 2nd ed. Baltimore, MD: Williams and Wilkins; 1998:45-76.
2. Dahlback B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1-43.
3. Koster T, Rosendaal FR, Briet E, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995;85:2756-2761.
4. Gandrille S, Borgel D, Sala N, et al. Protein S deficiency: a database of mutations - summary of the first update: for the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2000;84:918.
5. Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry. 1990;29:7845-7852.
6. Simmonds RE, Ireland H, Kunz G, Lane DA. Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis: Protein S Study Group. Blood. 1996; 88:4195-4204.
7. Rezende SM, Simmonds RE, Zoller B, et al. Genetic and phenotypic variability between families with hereditary protein S deficiency. Thromb Haemost. 2002;87:258-265.
8. van Wijnen M, Stam JG, Chang GTG, et al. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulinlike domain. Biochem J. 1998;330: 389-396.
9. Malm J, Cohen E, Dackowski W, Dahlback B, Wydro R. Expression of completely gamma-carboxylated and beta-hydroxylated recombinant human vitamin-K-dependent protein S with full biological activity. Eur J Biochem. 1990;187:737-743.
10. Dahlback B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem. 1990;265:8127-8135.
11. Zwaal RFA, Comfurius P, Bevers EM. Lipid-protein interactions in blood coagulation. Biochem Biophys Acta. 1998;1376:433-453.
12. Nelsestuen GL, Shah AM, Harvey SB. Vitamin K-dependent proteins. Vitam horm. 2000;58:355-389.
13. Stenflo J, Dahlback B. Vitamin K-dependent proteins. In: Stamatoyannopoulos G, Nienhuis AW, Mejerus PW, Varmus H, eds. The molecular basis of blood diseases. 2nd ed. Philadelphia, PA: WB Saunders; 1994:565-597.
14. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999;93:1798-1808.
15. Soriano-Garcia M, Padmanabhan K, devos AM, Tulinsky A. The calcium ion and membrane binding structure of the gla domain of Ca-prothrombin fragment 1. Biochemistry. 1992;31:2554-2566.
16. Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Biochemistry. 1995;34:12126-12137.
17. Banner DW, D'Arcy A, Chene C, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996; 380:41-46.
18. Mizuno H, Fujimoto Z, Atoda H, Morita T. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc Natl Acad Sci U S A. 2001;98:7230-7234.
19. Freedman SJ, Blostein MD, Baleja JD, Jacobs M, Furie BC, Furie B. Identification of the phospholipid binding site in the vitamin k-dependent blood coagulation protein factor IX. J Biol Chem. 1996; 271:16227-16236.
20. Cheung W-F, Straight D, Smith KJ, Lin S-W, Roberts HR, Stafford DW. The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cells. J Biol Chem. 1991;266:8797-8800.
21. Cheung W-F, Nobuko H, Smith KJ, Stafford DW. The binding of human factor IX to endothelial cells is mediated by residues 3-11. J Biol Chem. 1992;267:20529-20531.
22. Falls LA, Furie BC, Jacobs M, Furie B, Rigby AC. The omega-loop region of the human prothrombin gamma-carboxyglutamic acid domain penetrates anionic phospholipid membranes. J Biol Chem. 2001;276:23895-23902.
23. Christiansen WT, Jalbert LR, Robertson RM, Jhingan A, Prorok M, Castellino FJ. Hydrophobic amino acid residues of human anticoagulant protein C that contribute to its functional binding to phospholipid vesicles. Biochemistry. 1995;34: 10376-10382.
24. Jalbert LR, Chan JCY, Christiansen WT, Castellino FJ. The hydrophobic nature of residue-5 human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles. Biochemistry. 1996;35:7093-7099.
25. Zhang L, Castellino FJ. The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine 5 in the gamma-carboxyglutamic acid domain. J Biol Chem. 1994;269:3590-3595.
26. Nelsestuen GL, Kisiel W, Di Scipio RG. Interaction of vitamin K dependent proteins with membranes. Biochemistry. 1978;17:2134-2138.
27. McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlback B, Nelsestuen GL. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry. 1997;36:5120-5127.
28. Shah AM, Kisiel W, Foster DC, Nelsestuen GL. Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII. Proc Natl Acad Sci U S A. 1998;95:4229-4234.
29. Shen L, Shah AM, Dahlback B, Nelsestuen GL. Enhancement of human protein C function by site-directed mutagenesis of the gamacarboxyglutamic acid domain. J Biol Chem. 1998;273: 31086-31091.
30. Walker FJ. Regulation of activated protein C by protein S: the role of phospholipid in factor Va inactivation. J Biol Chem. 1981;256:11128-11131.
31. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76:1-16.
32. van Wijnen M, Stam JG, van't Veer C, et al. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost. 1996;76:397-403.
33. Long GL, Lu D, Xie RL, Kalafatis M. Human protein S cleavage and inactivation by coagulation factor Xa. J Biol Chem. 1998;273:11521-11526.
34. Hackeng TM, Hessing M, van't Veer C, et al. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C. J Biol Chem. 1993;268:3993-4000.
35. Smirnov MD, Safa O, Regan L, et al. A chimeric protein C containing the prothombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem. 1998; 273:9031-9040.
36. Villoutreix BO, Teleman O, Dahlback B. A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity. J Comput Aided Mol Des. 1997;11:293-304.
37. Christiansen WT, Geng J-P, Castellino FJ. Structure-function assessment of the role of the helical stack domain in the properties of human recombinant protein C and activated protein C. Biochemistry. 1995;34:8082-8090.
38. Gandriile S, Borgel D, Eschwege-Gufflet V, et al. Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood. 1995;85:130-138.
39. Larson PJ, Camire RM, Wong D, et al. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles. Biochemistry. 1998;37:5029-5038.
40. Ratcliffe JV, Furie B, Furie BC. The importance of specific gamma-carboxyglutamic acid residues in prothrombin: evaluation by site-specific mutagenesis. J Biol Chem. 1993;268:24339-24345.
41. Zhang L, Jhingan A, Castelino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood. 1992;80:942-952.
42. Larson PJ, Stanfield-Oakley SA, VanDusen WJ, et al. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa is required for its binding to cofactor VIIIa. J Biol Chem. 1996;271:3869-3876.
43. Giannelli F, Green PM, Sommer SS, et al. Hemophilia B: database of point mutations and short additions and deletions. Nucleic Acids Res. 1997; 25:133-135.
44. Hoskins J, Norman DK, Beckmann RJ, Long GL. Cloning and characterization of human liver cDNA encoding a protein S precursor. Proc Natl Acad Sci U S A. 1987;84:349-353.